Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: June 16, 2026Bookmark

A stroke is a sudden onset of brain dysfunction due to alterations in cerebrovascular blood supply. It is acute in onset and presents with focal neurological deficits (95% of the time).

The difference between a stroke and a transient ischaemic attack (TIA) is that a TIA is temporary and resolves within minutes to hours. A stroke is present if neurological signs last for more than 24 hours.

It peaks at 70+ years of age.

Definition of terms

TermDefinition
Transient ischaemic attackThis is essentially a ‘minor stroke’. It presents with stroke like symptoms which completely resolve within 24 hours. It is usually the result of micro-emboli (80%), but may be also be caused by mass lesions and massive postural hypotention.
Completed strokeThe clinical effects of stroke have reached their maximum (usually within 6 hours of onset)
Stroke in evolutionDescribes the progress of stroke in the first 24 hours
Amaurosis fugaxTransient, sudden, painless loss of vision in one eye caused by temporary lack of blood flow to the retina
Transient global amnesiaSudden, temporary episode of profound anterograde amnesia, often accompanied by mild retrograde amnesia with no other neurolgoical deficits

Presentation of stroke

CategoryPresentation
Suggests hemorrhage (unreliable)Meningism, severe headache, and coma
Suggests ischaemiaCarotid bruit, atrial fibrillation, history of TIA, and ischemic heart disease
Suggests cerebral infarction (50%)Contralateral sensory loss, contralateral hemiplegia (flaccid then spastic), dysphasia, homonymous hemianopia, and visuo-spatial defects
Suggests brainstem infarction (25%)Quadriplegia, gaze, vision and balance disturbance, land ocked-in syndrome
Suggests lacunar infarction (25% – basal ganglia, internal capsule, thalamus, and pons)Ataxic hemiparesis, pure motor loss, pure sensory loss, sensorimotor loss, dysarthria, involuntary movements (clusmy hand), impaired cognition and consciousness in thalamic stroke
  • Risk factors for stroke
  • Signs and symptoms
    • Facial drooping
    • One-sided weakness of the arm or leg
    • Verbal deficit: slurring, dysarthria, aphasia, verbal agnosia
    • Altered level of consciousness
  • Differential diagnosis
    • Head injury
    • Hypoglycaemia or Hyperglycaemia
    • Subdural hemorrhage
    • Focal-onset seizure with Todd’s paralysis
    • Intracranial neoplasm
    • Wernicke’s encephalopathy
    • Hepatic encephalopathy
    • Toxoplasmosis
    • Encephalitis
    • Cerebral abscess
    • Complicated migraine
  • Investigations
    • Non-contrast CT to distinguish and ischemic from a hemorrhagic stroke. It takes 6 hours for the CT scan to develop hypodensities. A hyperacute stroke can present with a normal head CT. It shoudl be repeat in 3 days
      • Dense MCA sign is seen in MCA occlusion
      • Dense Basilar artery is seen in basilar artery occlusion
      • Haemorrhagic stroke presents with hyperdensity (corresponding to blood)
    • Brain MRI without contrast after acute treatment. ****
      • DWI sequence is the gold standard (water cannot diffuse within infarcted tissue and shows hyperintensity).
      • DWI is checked against the ADC sequence.
    • Vacular imaging
      • CT angiography of the head with contrast in emergency cases. Carries risk of contrast nephropathy and is susceptible to bone artefacts
      • MR angiography of the head with/without gadolinium in non-emergency cases or patient that should not be repeatedly radiated. Gadolinium can be used in the workup for intracranial hemorrhage.
      • Carotid Doppler for blockage
    • Blood Glucose to exclude hypoglycemia, which can mimic stroke
    • Coagulation profile for PT and INR.
    • Electrocardiogram for A-fib
    • Echocardiogram for intraventricular or intraatrial thrombi, dilated cardiomyopathy and valvular heart disease
    • Lipid panel for LDL
    • Complete blood count for platelets
  • Treatment
    • 7 S’s
      • Significant history and Systemic anticoagulation (stroke risk factors and last dose of anticoagulant)
      • Symptom onset time (time last normal for viable brain tissue)
      • Symptoms and deficits (for targeted neurological examination)
      • Systolic blood pressure (may need to be adjusted)
      • Sinus rhythm (A-fib may be present)
      • Stroke laboratory investigations (CBC, RBS, UEC, LFTs, coagulation panel)
      • Stroke scale (NIH stroke scale to screen for disabling deficits and localize lesions)
    • Secure Airway to prevent aspiration and hypoxia
    • Supplemental Oxygen if SpO2 < 94%
    • 2 Large bore IV access
    • Control Blood Pressure immediately if > 220 mmHg systolic
      • Generally aim for ≤ 185/110
      • Reduce MAP by 15% in the first 24 hours for acute ischemic stroke without fibrolysis
      • Reduce MAP by 15% over 1 hour for acute ischemic stroke with fibrolysis
      • Target 140 systolic within the first 24 hours in Haemorrhagic stroke
    • Maintain homeostasis
      • Treat hypoglycemia if < 4.4 mmol/L
      • Antipyretics (Acetaminophen) if Temperature is > 38 C
    • Nil per oral until the patient is screened for swallowing
    • High-dose aspirin once hemorrhagic stroke is excluded
    • Admissios to the ICU or stroke unit
  • Primary prevention
  • Secondary prevention
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team